DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Naltriben
Naltriben
(12) Patent Application Publication (10) Pub. No.: US 2004/0224020 A1 Schoenhard (43) Pub
TABLE 1 Studies of Antagonist Activity in Constitutively Active
A,-, and P-Opioid Receptor Agonists on Excitatory Transmission in Lamina II Neurons of Adult Rat Spinal Cord
Zebrafish Behavioral Profiling Links Drugs to Biological Targets and Rest/Wake Regulation
In Vivoactivation of a Mutantμ-Opioid Receptor by Naltrexone Produces A
Opioid Receptorsreceptors
4 Supplementary File
Constitutive Activity of the Δ-Opioid Receptor Expressed in C6 Glioma Cells
A 0.70% E 0.80% Is 0.90%
Blockade of O-Opioid Receptors Prevents Morphine-Induced Place Preference in Mice
NIDA Drug Supply Program Catalog, 25Th Edition
(12) Patent Application Publication (10) Pub. No.: US 2014/0144429 A1 Wensley Et Al
Sfn2015 Items of Interest
A Phase 2A Study to Evaluate the Kappa Opioid Receptor As a Target
A Role for Heterodimerization of and Opiate Receptors in Enhancing Morphine Analgesia
Morphine Preconditions Purkinje Cells Against Cell Death Under in Vitro Simulated Ischemia–Reperfusion Conditions
Proteostasis of Glial Intermediate Filaments: Disease Models, Tools, and Mechanisms
PET Radiochemistry for the Investigation of the Biology of Pain and Inflammation
Top View
Effects of Naltrexone Alone and in Combination with Acamprosate on the Alcohol Deprivation Effect in Rats
Cellular and Molecular Mechanisms of Transient Receptor Potential Melastatin 7 (TRPM7) Channel in Neuronal Development and Injury
BBC Program 2015 3.5.15
Pharmacokinetics, Metabolism, and Pharmaceutics of Drugs of Abuse
PROGRAM BOOK Table of Contents
Investigating the Anti-Cocaine, Anti-Nociceptive Properties and Side Effects of MP1104, a Novel Mixed Opioid Receptor Agonist
Investigating Mechanisms Regulating the in Vivo Actions of Delta Opioid Receptor Ligands
Omega Laboratories, Inc. Robert Bard Managing Director 400 North Cleveland Mogadore Oh 44260
Using Δ-Opioid Receptor Agonists to Protect Skeletal Muscle Against Low Ph Hypoxic Damage Melissa A
Mitigation of NADPH Oxidase 2 Activity As a Strategy to Inhibit Peroxynitrite Formation
(12) United States Patent (10) Patent No.: US 8,058,243 B2 Tyers Et Al
Functional Imaging of Neural Systems Associated with Alcohol Reward and Amphetamine Toxicity
Pharmacology and Toxicology
Lysophosphatidic Acid Receptor Agonism: Discovery of Potent Non-Lipid Benzofuran Ethanolamine Structures
Lysophosphatidic Acid Receptor Agonism: Discovery of Potent Nonlipid Benzofuran Ethanolamine Structures S
Known Bioactive Library: Tocriscreen Mini Library 2
Naltrexone/Nalbuphine Elisa Kit Instructions Product #133019 & 133015 (Rtu) Forensic Use Only
An Improved Antagonist Radiotracer for the K-Opioid Receptor: Synthesis and Characterization of 11C-LY2459989
Hartsock Ku 0099D 11079 DA
Molecular Control of D-Opioid Receptor Signalling
Mosser Et Al Figs 190702
Identification and Analysis of Hepatitis C Virus NS3 Helicase Inhibitors Using Nucleic Acid Binding Assays
Label-Free Integrative Pharmacology On-Target of Opioid Ligands at The
Opioids and Their Complicated Receptor Complexes Bryen A
Alcohol Inhibition of NK Cell Function Opioid Receptors in Splenocytes to Prevent Δ and Μ Feedback Interaction Between Opioid
TIP 28: Naltrexone and Alcoholism Treatment
Confers Full Agonistic Properties to Classical Antagonists PATRICIA A
Modulation of Opiate-Related Signaling Molecules in Morphine-Dependent Conditioned Behavior: Conditioned Place Preference to Morphine Induces CREB Phosphorylation
Andμ-Opioid Receptors
Bifunctional Opioid Peptidomimetics: Studies on Affinity and Efficacy By
Agonist-Induced Phosphorylation Bar Code and Differential Post-Activation Signaling of the Delta Opioid Receptor Revealed by Phosphosite-Specific Antibodies
Inhibitory Effect of Deltorphin-II on Development of Malaria in Plasmodium Berghei-Infected Mice
Known Bioactive Library: LOPAC 1
Neogen Forensic Catalog
Enhanced Intranasal Absorption of Naltrexone by Dodecyl
Naltrexone and Alcoholism Treatment 28: Treatment Improvement Protocol (TIP) Series 28
Characterization of 8 Opioid Receptors in Lung Cancer Using a Novel Nonpeptidic Ligand1
Carisoprodol Elisa Kit Instructions Product #132519 & 132515 (Rtu) Forensic Use Only